MAM
CVS icon

Mastrapasqua Asset Management’s CVS Health CVS Stock Holding History

Mastrapasqua Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,650
Closed -$1.03M – 145
2020
Q3 		$1.03M Sell
17,650
-69,611
-80% -$4.33M 0.14% 103
2020
Q2 		$5.67M Buy
87,261
+1,871
+2% +$118K 0.87% 43
2020
Q1 		$5.07M Buy
85,390
+7,180
+9% +$479K 0.98% 42
2019
Q4 		$5.81M Buy
78,210
+70,300
+889% +$4.94M 0.96% 43
2019
Q3 		$499K Buy
+7,910
New +$469K 0.09% 118
2019
Q1 		– Sell
-10,837
Closed -$710K – 130
2018
Q4 		$710K Buy
10,837
+6,647
+159% +$496K 0.16% 105
2018
Q3 		$330K Hold
4,190
– – 0.06% 122
2018
Q2 		$270K Hold
4,190
– – 0.05% 132
2018
Q1 		$261K Hold
4,190
– – 0.05% 136
2017
Q4 		$304K Sell
4,190
-85
-2% -$6.18K 0.06% 135
2017
Q3 		$348K Buy
4,275
+505
+13% +$39.9K 0.07% 137
2017
Q2 		$303K Hold
3,770
– – 0.07% 142
2017
Q1 		$296K Sell
3,770
-91,188
-96% -$7.28M 0.07% 138
2016
Q4 		$7.49M Sell
94,958
-2,436
-3% -$197K 1.81% 16
2016
Q3 		$8.67M Sell
97,394
-3,062
-3% -$289K 2.13% 10
2016
Q2 		$9.62M Sell
100,456
-1,916
-2% -$191K 2.4% 8
2016
Q1 		$10.6M Sell
102,372
-2,842
-3% -$276K 2.48% 9
2015
Q4 		$10.3M Sell
105,214
-775
-0.7% -$75.9K 2.53% 8
2015
Q3 		$10.2M Sell
105,989
-452
-0.4% -$47.5K 2.7% 6
2015
Q2 		$11.2M Buy
106,441
+80,571
+311% +$8.23M 2.7% 5
2015
Q1 		$1.78M Sell
25,870
-84,312
-77% -$8.53M 3.51% 3
2014
Q4 		$10.6M Buy
+110,182
New +$9.71M 2.55% 4
2014
Q2 		$9.37M Sell
124,352
-2,685
-2% -$203K 2.16% 7
2014
Q1 		$9.51M Sell
127,037
-8,860
-7% -$626K 2.23% 4
2013
Q4 		$9.73M Sell
135,897
-1,123
-0.8% -$72.2K 2.21% 4
2013
Q3 		$7.78M Buy
137,020
+484
+0.4% +$28.8K 1.91% 8
2013
Q2 		$7.81M Buy
+136,536
New +$7.91M 2.07% 9

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Mastrapasqua Asset Management's CVS Position: Q4 2020 in Review

Mastrapasqua Asset Management sold out of CVS Health (CVS) in Q4 2020, closing a stake of 17,650 shares — an estimated $1.03M sold.

Mastrapasqua Asset Management first reported a position in CVS in Q2 2013 and held it in 27 quarters. The position peaked at $11.2M in Q2 2015. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Mastrapasqua Asset Management reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
  • Mastrapasqua Asset Management sold 17,650 CVS Health shares in Q4 2020, an estimated $1.03M.
  • Mastrapasqua Asset Management first reported a position in CVS Health in Q2 2013 and held it in 27 quarters.
  • Mastrapasqua Asset Management's CVS Health position peaked at $11.2M in Q2 2015.
  • 1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Mastrapasqua Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.